Therapy Areas: Vaccines
India may consider vaccinating children with Cadila's COVID-19 vaccine from October 2021
22 September 2021 -

Indian children aged 12 or older will become eligible for COVID-19 vaccinations from next month, when Indian pharmaceutical company Cadila Healthcare (NSE:CADILAHC) launches its ZyCoV-D product, Reuters news agency reported on Wednesday, citing two sources with direct knowledge of the matter.

ZyCoV-D , the world's first DNA-based COVID-19 vaccine, won emergency authorisation from Indian regulators last month.

From October 2021, the company, better known as Zydus Cadila, is expected to produce 10 million doses a month.

This COVID-19 vaccine is the only one approved for children in India, Reuters added.